PRETRANSLATIONAL REGULATION OF CYTOCHROME-P450 GENES IS RESPONSIBLE FOR DISEASE-SPECIFIC CHANGES OF INDIVIDUAL P450 ENZYMES AMONG PATIENTS WITH CIRRHOSIS

被引:92
作者
GEORGE, J [1 ]
LIDDLE, C [1 ]
MURRAY, M [1 ]
BYTH, K [1 ]
FARRELL, GC [1 ]
机构
[1] UNIV SYDNEY,WESTMEAD HOSP,DEPT GASTROENTEROL & HEPATOL,STORR LIVER UNIT,WESTMEAD,NSW 2145,AUSTRALIA
关键词
CYTOCHROME P450; CYP; CYP REGULATION; CYP1A2; CYP2E1; CYP2C9; CYP3A4; HUMAN CIRRHOSIS; LIVER DISEASE;
D O I
10.1016/0006-2952(94)00515-N
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have recently reported that disease-specific differential alterations in the hepatic expression of xenobiotic-metabolizing cytochrome P450 (CYP P450) enzymes occur in patients with advanced liver disease. In order to determine whether the observed changes in CYP proteins are modulated at pre- or post-translational levels, we have now examined the hepatic levels of mRNA for CYPs 1A2, 2C9, 2E1 and 3A4 by solution hybridization in the same livers of 20 controls (surgical waste from histologically normal livers), 32 cases of hepatocellular and 18 of cholestatic severe chronic liver disease. CYP1A2 mRNA and CYP1A immunoreactive protein were both reduced in livers with hepatocellular and cholestatic types of cirrhosis. In contrast, CYP3A4 mRNA and protein were reduced only in livers from patients with hepatocellular diseases. For 1A2 and 3A4 there were significant correlations between mRNA species and the respective protein contents (r(S1A2) = 0.74, r(S3A4) = 0.64, P<0.0001). CYP2C9 mRNA was reduced in patients with both cholestatic and hepatocellular types of liver disease, but 2C protein was reduced only in patients with cholestatic dysfunction. The correlation between CYP2C9 mRNA and protein, was also significant (r(s) = 0.36, P<O.OO5) but mRNA levels accounted for only 13% of the variability in protein rankings. This is probably a consequence of other CYP2C proteins apart from 2C9 being detected by the anti-2C antibody. CYP2E1 mRNA and protein were reduced in patients with cholestatic liver disease, but in hepatocellular disease the expression of only CYP2E1 mRNA was decreased. CYP2E1 mRNA was significantly correlated with CYP2E1 protein but accounted for only 18% of the variability in protein rankings (r(s) = 0.43, P<0.0005). Taken collectively these data indicate that the disease-specific alterations of xenobiotic-metabolizing CYP enzymes among patients with cirrhosis is due, at least in part, to pre-translational mechanisms. The lack of a strong correlation between CYP2E1 mRNA and protein suggests that this gene, like its rat orthologue, may be subject to pre-translational as well as translational and/or post-translational regulation.
引用
收藏
页码:873 / 881
页数:9
相关论文
共 44 条
  • [1] ETHANOL INTERFERES WITH REGENERATION-ASSOCIATED CHANGES IN BIOTRANSFORMING ENZYMES - A POTENTIAL MECHANISM UNDERLYING ETHANOLS CARCINOGENICITY
    DIEHL, AM
    BISGAARD, HC
    KREN, BT
    STEER, CJ
    [J]. HEPATOLOGY, 1991, 13 (04) : 722 - 727
  • [2] A PRACTICAL APPROACH FOR QUANTITATING SPECIFIC MESSENGER-RNAS BY SOLUTION HYBRIDIZATION
    DURNAM, DM
    PALMITER, RD
    [J]. ANALYTICAL BIOCHEMISTRY, 1983, 131 (02) : 385 - 393
  • [3] LIGAND-DEPENDENT MAINTENANCE OF ETHANOL-INDUCIBLE CYTOCHROME-P-450 IN PRIMARY RAT HEPATOCYTE CELL-CULTURES
    ELIASSON, E
    JOHANSSON, I
    INGELMANSUNDBERG, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 150 (01) : 436 - 443
  • [4] PHARMACOKINETICS OF NIFEDIPINE AFTER ORAL-ADMINISTRATION IN CHRONIC LIVER-DISEASE
    ENE, MD
    ROBERTS, CJC
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (12) : 1001 - 1004
  • [5] DRUG-METABOLISM IN LIVER-DISEASE - ACTIVITY OF HEPATIC MICROSOMAL METABOLIZING ENZYMES
    FARRELL, GC
    COOKSLEY, WGE
    POWELL, LW
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) : 483 - 492
  • [6] RELATIVE EXPRESSION OF CYTOCHROME P450 ISOENZYMES IN HUMAN LIVER AND ASSOCIATION WITH THE METABOLISM OF DRUGS AND XENOBIOTICS
    FORRESTER, LM
    HENDERSON, CJ
    GLANCEY, MJ
    BACK, DJ
    PARK, BK
    BALL, SE
    KITTERINGHAM, NR
    MCLAREN, AW
    MILES, JS
    SKETT, P
    WOLF, CR
    [J]. BIOCHEMICAL JOURNAL, 1992, 281 : 359 - 368
  • [7] GEORGE J, IN PRESS HEPATOLOGY
  • [8] GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243
  • [9] HUMAN P450PCN1 - SEQUENCE, CHROMOSOME LOCALIZATION, AND DIRECT EVIDENCE THROUGH CDNA EXPRESSION THAT P450PCN1 IS NIFEDIPINE OXIDASE
    GONZALEZ, FJ
    SCHMID, BJ
    UMENO, M
    MCBRIDE, OW
    HARDWICK, JP
    MEYER, UA
    GELBOIN, HV
    IDLE, JR
    [J]. DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1988, 7 (02): : 79 - 86
  • [10] GUENGERICH FP, 1991, J PHARMACOL EXP THER, V256, P1189